Mechanism study reveals that FABP5 silencing reduces intracellular fatty acid (FA) levels then suppressed NF‐κB signalling that leads to reduction of the downstream target genes in breast cancer cells.39 This evidence concerns the gene FABP5 and breast carcinoma.